KENNETH JONES: Open Payments
NPI 1548344096 · NORTH CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$345 in 13 payments from 7 companies in 2025. Trend: 2023 $308 · 2024 $447 · 2025 $345
Food & beverage: $345
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 1 | $97 |
| Novartis Pharmaceuticals Corporation | 4 | $82 |
| Exact Sciences Corporation | 3 | $51 |
| Neurocrine BioSciences, Inc. | 2 | $41 |
| Novo Nordisk Inc | 1 | $31 |
| Viatris Specialty LLC | 1 | $24 |
| Dexcom, Inc. | 1 | $19 |
Products named: Yeztugo, LEQVIO, INGREZZA, The Cologuard Plus Collection Kit, Ozempic, YUPELRI, Dexcom G6 Transmitter, Cologuard Collection Kit.
Industry payments across SC — which companies pay providers there.
